NDC 45802-211
alogliptin and metformin hydrochloride
Alogliptin And Metformin Hydrochloride
alogliptin and metformin hydrochloride is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Perrigo New York Inc. The primary component is Alogliptin Benzoate; Metformin Hydrochloride.
| Product ID | 45802-211_23cc30bd-4615-442b-9f1f-6926e54d7998 |
| NDC | 45802-211 |
| Product Type | Human Prescription Drug |
| Proprietary Name | alogliptin and metformin hydrochloride |
| Generic Name | Alogliptin And Metformin Hydrochloride |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2016-04-08 |
| Marketing Category | NDA / NDA |
| Application Number | NDA203414 |
| Labeler Name | Perrigo New York Inc |
| Substance Name | ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE |
| Active Ingredient Strength | 13 mg/1; mg/1 |
| Pharm Classes | Dipeptidyl Peptidase 4 Inhibitors [MoA],Dipeptidyl Peptidase 4 Inhibitor [EPC],Biguanide [EPC],Biguanides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |